Eight domestically-produced drugs that are seen as "major innovations" and have just hit the market in recent years are among the new additions, said… [more]
Aimed at addressing prominent problems of the pharmaceutical industry, such as counterfeit and substandard drugs and high drug prices, the revised la… [more]
In recent years, the export of formulations has become one of the important signs of Chinese pharmaceutical companies going global. In 2018, China's … [more]
From 2014 to 2016, the Russian economy has been trapped in negative growth. In 2017, it gradually emerged from the economic downturn. According to th… [more]
"The 4th Award for Top 100 Internationalized Pharmaceutical Companies" was announced at "The 10th CPhI China-World CEO Summit" held in Shanghai on Ju… [more]
CCCMPHIE will release the Report on Dietary Supplement Industry (2019) (the “Report”) at the HNC2019 on June 21, 2019. The Report introduces the di… [more]
Last year saw further improvement of China's healthcare service capacity, with the medical and health workers totalling 12.3 million as of the end of… [more]
The East African Community (EAC) is set to launch a cross-border disease preparedness exercise in Namanga, a border town between Kenya and Tanzania i… [more]
Market looks well set for regional boom as second CPhI Middle East & Africa launches in Dubai [more]
A year after Torrent Pharmaceuticals first began recalling tainted losartan products manufactured at its Indrad plant, the FDA paid a visit. It found… [more]
Rapid Medical, an Israeli company focused on the development of next generation neurovascular devices has announced that its Comaneci device received… [more]
China has launched a new biomedical research center for mammalian and medical synthetic biology in Shanghai, according to the China Daily Wednesday. [more]
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, has announced that it has acq… [more]
Genentech, a member of the Roche Group has announced that the U.S. Food and Drug Administration (FDA) has approved Kadcyla (ado-trastuzumab emtansine… [more]